1117-AB51 201910 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 1117 Drug Enforcement Administration DEA 1100 Department of Justice DOJ Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants

DEA proposes adjusting the fee schedule for DEA registration and reregistration fees necessary to recover the costs of its Diversion Control Program relating to the registration and control of the manufacture, distribution, dispensing, importation and exportation of controlled substances and List I chemicals as mandated by the Controlled Substances Act.

]]> Other Significant Previously Published in The Unified Agenda Proposed Rule Stage Yes No Other 21 CFR 1301.13 21 CFR 1309.11 21 CFR 1309.21 21 U.S.C. 821 21 U.S.C. 886a 21 U.S.C. 958(f) No NPRM 12/00/2019 No Businesses None No No No Scott Brinks A. Section Chief, Regulatory Drafting and Support Section, Diversion Control Division 1117 Drug Enforcement Administration DEA 571 362-8209 scott.a.brinks@dea.gov 8701 Morrissette Drive, Springfield VA 22152